Pharmacovigilance – News and Features

Scientists have revealed how minerals play a role in the complexity of female fertility and the menstrual cycle. The review looks at several minerals and how they impact hormonal regulation, ovarian function and ovulation, endometrial health and oxidative stress.

For the first time in fifty years, results from a phase 3 randomized, placebo-controlled trial have shown an overall survival benefit from an adjuvant therapy in patients with kidney cancer.

Antipsychotic use in people with dementia is associated with elevated risks of a wide range of serious adverse outcomes including stroke, blood clots, heart attack, heart failure, fracture, pneumonia, and acute kidney injury, compared with non-use.

Researchers have linked a region in the brain to how humans redirect thoughts and attention when distracted, offering insights into side effects of Parkinson's disease treatment.

3D-printed films loaded with drugs could be used to kill cancer cells while minimizing the toxicity of traditional chemotherapy.

Contrary to past warnings, a new study has found that a commonly prescribed dementia drug doesn't increase the risk of death or heart rhythm problems.

A drug used to treat children with epilepsy prevents brain tumor formation and growth in two mouse models of neurofibromatosis type 1 (NF1), according to a study by researchers at Washington University School of Medicine in St. Louis.

A University of Michigan study has shown that traumatic experiences during childhood may get “under the skin” later in life, impairing the muscle function of people as they age.

Use of antibiotics provided no measurable impact on the severity or duration of coughs, even if a bacterial infection was present, finds a large prospective study.

Rice University engineers have developed the smallest implantable brain stimulator demonstrated in a human patient. Thanks to magnetoelectric power transfer technology, the pea-sized device can be powered wirelessly.